Renal services: Offering complete inpatient dialysis services while managing hospital dialysis operations at every level. Our Quality Assessment and Performance Improvement (QAI) Program is specifically designed to respond to the unique challenges presented in the inpatient care setting.
Transitional renal services: Providing a single source solution for integrated care by optimizing care coordination and providing a smooth transition from inpatient to outpatient care.
Additional therapy services: Offering a wide range of therapeutic apheresis therapies that can accomplish prescribed therapy at the patient’s bedside. Our UFComplete Program offers ultrafiltration/fluid surveillance services for congestive heart failure patients.
- Peritoneal dialysis
- Continuous Renal Replacement Therapy (CRRT )
- Sustained Low-Efficiency Daily Dialysis (SLEDD)
We provide superior clinical programs, collaborative hospital control efforts and partnership with hospital staff and physicians, providing effective dialysis treatments for:
- Dialysis patients requiring treatment during episodes of hospitalization
- Trauma victims or drug overdose patients with temporary loss of kidney function
- Patients suffering from acute poisoning and acute kidney injury
- ICU Patients requiring Continuous Renal Replacement Therapy (CRRT) or Sustained Low-Efficiency Daily dialysis (SLEDD)
Renal services include:
- Licensed inpatient dialysis nurses and certified technicians
- National policies and procedures and National Quality Assessment and Improvement Program (QAI)
- Water treatment standards that meet AAMI guidelines
- Dialysis specific supplies needed to perform treatments
- General liability and malpractice insurance for our staff
Quality Assessment and Performance Improvement program (QAI)
Our Quality Assessment and Performance Improvement Program is a pro-active, systematic process that monitors and improves the quality of patient care as measured by indicators tailored for the inpatient setting.
The QAI Program monitors, evaluates and recommends improvement activities focused on relevant indicators that impact patient care and clinical performance.
Quality categories monitored:
- Staff credentialing and competency
- Patient safety
- Staff safety
- Customer and patient satisfaction
- Equipment safety
- Adverse event reporting
- Water quality
- Infection control
- Risk management
Benefits of QAI program:
- Multidisciplinary collaboration with hospital in support of clinical quality improvement initiatives and cost control efforts
- Exceeds regulatory oversight requirements
- Assists hospital in regulatory preparedness
- Standardized data collection and regular hospital reporting
An interdisciplinary team of physicians, nurses, quality management, technical and other acute dialysis experts designed this program specifically for the unique challenges presented in the inpatient care setting.
Transitional renal services
Healthcare team walks with patient who is being discharged
Nurse and doctor in hospital ICU setting comparing medical record history notes
Our transitional renal services focus on improving patient care through quality oversight, care coordination and patient education while the patient is in the hospital.
Transitional renal services include:
- Renal Inpatient Care Manager (RICM) Program
- Discharge planning – Treatment Options Education (TOPs™)
- Vascular access coordination
- Monitoring readmission risk
Renal Inpatient Care Management program (RICM)
Through the RICM program, we provide acute care hospitals the services of a dedicated Inpatient Care Manager who is a registered nurse with significant dialysis experience to work collaboratively, with hospital case managers, nephrologists, attending physicians, nurses and other hospital and outpatient colleagues, to help ensure a comprehensive plan of care for renal patients.
Case Study: Reductions in readmissions & LOS
Accomplished through collaboration facilitated by Renal Inpatient Care Manager
13% Reduction in readmissions
1.7 Days reduction in LOS
Crit-Line® Blood Volume Monitoring
The Inpatient Services Program provides superior clinical care through the Crit-Line® Blood Volume Monitor. This innovative technology:
- Continuously measures blood volume and hematocrit to guide clinical practices that can optimize therapy with minimal side effects;
- Graphically shows how the patient tolerates the therapy, and provides evidence for the clinician to maintain or modify the dialysis prescription.
Additional therapy services include:
Additional inpatient services that we support include Therapeutic Apheresis, and Ultrafiltration for Congestive Heart Patients (UFComplete™)
Therapeutic apheresis services
We provide comprehensive and high quality apheresis patient care while reducing the cost of these services to hospitals.
We partner with more than 350 hospitals, performing 25,000 apheresis treatments annually. Our expertise consists of:
- 25 years of clinical apheresis experience
- Program creation, development and management
- Extensive nurse and physician education
- Thought leadership through contributions to published content
- Development of national treatment guidelines
- Utilization of state-of-the-art equipment and technology
- Therapeutic plasma exchange
- Red blood cell exchange
- LDL apheresis
- Peripheral stem cell collection
- Cell collection for clinical research
Diseases commonly treated with apheresis
- Thrombotic Thrombocytopenic Purpura (TTP)
- Guillain-Barre Syndrome (GBS)
- Myasthenia gravis
- Autoimmune polyneuropathies
- Waldenstrom’s macroglobulinemia
- Goodpasture’s syndrome
- Rapidly progressive glomerulonephritis
- Sickle cell disease
- Pulmonary renal syndrome
Value added apheresis services
- State of the art apheresis equipment
- Specially trained registered nurses
- Medical Director Oversight
- Staff/physician education
- Quality Improvement Program
- Monthly outcomes reporting
- Physician to physician consultation
- Evidence based practice
A complete fluid management program for heart failure / fluid overload:
Help improve outcomes for congestive heart failure patients with fluid overload with a therapy recommended by leading heart failure experts for patients who have failed conventional diuretic therapies.
The goal of treating patients who have congestive heart failure with fluid overload is to achieve “evolemia ” — a state of optimal weight and fluid status in the body. Yet patients are often discharged before euvolemia is achieved, placing them at high risk for recurrence of fluid overload, early hospital readmission and longer length of stays.
For congestive heart failure patients failing conventional treatments for fluid overload, we believe ultrafiltration is the right treatment choice because it:
- Offers more precise control over the fluid removal rate and the total amount of fluid removed.
- Removes high amount of sodium
- Supports sustained weight loss
The UNLOAD Study5:
At 90 days, ultrafiltration reduced admissions.
Benefits of partnering with UFComplete:
- Clinical guidance from the UFComplete team regarding the creation/evaluation of evidence-based order sets, policies and procedures.
- Flexibility in choice of ultrafiltration device and services, with no fixed costs.
- Nursing resources, including staff trained in extracorporeal therapies to set up/take down the machines and assist with trouble shooting.
- Help to reduce length of stay through early therapy initiation and avoidable readmissions through defined inpatient and outpatient programs.
- Assistance to hospitals to help avoid financial penalties (Medicare Readmission Penalty)